Free press releases distribution network?

Agency / Source: Becton, Dickinson and Company

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BD Launches Making Safety SaferSM Campaign - Resource now available to help clinicians reduce risk of blood exposure from short peripheral IV catheter insertion
BD Launches Making Safety SaferSM Campaign


PRZOOM - /newswire/ - Sandy, UT, United States, 2011/05/03 - Resource now available to help clinicians reduce risk of blood exposure from short peripheral IV catheter insertion. NYSE: BDX

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Healthcare workers now have the ability to better identify risks for exposure to bloodborne pathogens, take precautions to better protect themselves, and share information and experiences as a result of a new program developed by BD Medical, a segment of BD (Becton, Dickinson and Company) and the world’s leading provider of IV catheters.

The BD Making Safety SaferSM program will provide nurses and other healthcare professionals with a forum to share information on risks, precautions and interventions, learn from experts and peers, and assist hospitals and other healthcare organizations in addressing ongoing concerns relating to blood exposure due to insertion of a short peripheral IV catheter (SPIVC).

Cheryll Collins, BSN, RN, OCN was exposed to blood from a patient infected with HIV and Hepatitis C. “As I unhooked the [needle] chamber, the patient pulled her arm away. The blood that was left in the hub went straight across my face and into my eye,” said Collins. “That incident had a profound impact on my life, as well the lives of my husband and family.” To view a video of her personal story, visit

“Although the healthcare industry has come a long way in reducing the risk of needlestick injuries and their potential dangers, mucocutaneous blood exposure during a short peripheral IV catheter insertion is still a risk today,” said John Ledek, Vice President, BD Medical - Medical Surgical Systems. “BD created this educational resource to enable clinicians to better protect themselves.”

This program will help educate nurses to approach short peripheral IV insertion with more caution, such as using appropriate personal protective equipment and taking other appropriate precautions to better protect themselves from contaminated blood.

BD also is sponsoring online forums on blood safety and inviting clinicians to learn and share their experiences. Visit to access these resources online.

SPIVCs are the most commonly used device to access a patient’s blood vessels. Blood exposure, including exposure that may occur upon insertion of an SPIVC, presents a risk to clinicians and patients. According to multiple published studies, up to 37.8 percent of healthcare workers report having experienced at least one blood or body fluid exposure in the preceding year 1,2,3. A recent report from the International Healthcare Worker Safety Center at the University of Virginia shows that nurses are at greatest risk, reporting 48.6 percent of blood or bodily fluid exposures4.

About BD
BD ( is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

1 Doebbeling BN, Vaughn TE, McCoy KD, Beekmann SE, Woolson RF, Ferguson KJ, et al. Percutaneous injury, blood exposure, and adherence to standard precautions: are hospital-based health care providers still at risk? Clin Infect Dis. 2003 Oct 15;37(8):1006-13.

2 Zhang M, Wang H, Miao J, Du X, Li T, Wu Z. Occupational exposure to blood and body fluids among health care workers in a general hospital, China. Am J Ind Med. 2009 Feb;52(2):89-98.

3 Tarantola A, Koumare A, Rachline A, Sow PS, Diallo MB, Doumbia S, et al. A descriptive, retrospective study of 567 accidental blood exposures in healthcare workers in three West African countries. J Hosp Infect. 2005 Jul;60(3):276-82.

4 EPINet. International Healthcare Worker Safety Center, University of Virginia. U.S. Blood and Body Fluid Exposure Report. 2007 [Mar 7, 2011]

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: Becton, Dickinson and Company


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

BD Launches Making Safety SaferSM Campaign

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
BD |
Contact: Barbara Kalavik - 
201-847-4209 barbara_kalavik[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Becton, Dickinson and Company securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From Becton, Dickinson and Company / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy
Greenphire Continues Commitment to Clinical Research Site Sustainability and Innovation at Global Site Solutions Summit
Frost & Sullivan Highlights argenx for Enhancing the Therapeutic Qualities of Human Antibodies with its Proprietary Antibody Discovery Platform, SIMPL
FDA Grants Breakthrough Therapy Designation for Genentech’s Actemra® (Tocilizumab) in Giant Cell Arteritis, a Form of Vasculitis

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



Visit  MagLar, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona

  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today